What is William Blair’s Estimate for Exponent Q1 Earnings?

Exponent, Inc. (NASDAQ:EXPO) – Research analysts at William Blair reduced their Q1 2025 EPS estimates for Exponent in a report issued on Friday, February 7th. William Blair analyst A. Nicholas now anticipates that the business services provider will earn $0.48 per share for the quarter, down from their prior estimate of $0.56. The consensus estimate for Exponent’s current full-year earnings is $2.11 per share. William Blair also issued estimates for Exponent’s Q4 2025 earnings at $0.43 EPS, Q1 2026 earnings at $0.53 EPS, Q2 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.58 EPS, Q4 2026 earnings at $0.48 EPS and FY2026 earnings at $2.19 EPS.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.76%. During the same quarter in the prior year, the firm earned $0.41 earnings per share.

Exponent Trading Down 0.0 %

Exponent stock opened at $90.86 on Monday. The company has a market capitalization of $4.61 billion, a PE ratio of 42.86 and a beta of 0.71. The stock has a 50-day moving average price of $91.82 and a two-hundred day moving average price of $100.55. Exponent has a 12 month low of $74.30 and a 12 month high of $115.75.

Institutional Trading of Exponent

Several large investors have recently modified their holdings of EXPO. Barclays PLC boosted its holdings in Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock worth $11,127,000 after acquiring an additional 66,263 shares in the last quarter. Geneva Capital Management LLC increased its stake in Exponent by 1.7% during the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the last quarter. Argent Capital Management LLC lifted its stake in shares of Exponent by 17.3% in the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock valued at $2,524,000 after buying an additional 4,173 shares in the last quarter. Finally, Citigroup Inc. grew its holdings in shares of Exponent by 174.7% during the third quarter. Citigroup Inc. now owns 48,309 shares of the business services provider’s stock valued at $5,569,000 after buying an additional 30,723 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insider Buying and Selling

In other Exponent news, Director Paul R. Johnston sold 1,300 shares of Exponent stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total value of $123,539.00. Following the completion of the sale, the director now directly owns 59,406 shares in the company, valued at approximately $5,645,352.18. The trade was a 2.14 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is owned by corporate insiders.

Exponent Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.32%. This is a positive change from Exponent’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 7th. Exponent’s payout ratio is presently 52.83%.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.